Carmen Valcarce

vTv Therapeutics LLC is a clinical-stage biopharmaceutical company which engages in the discovery and development of small molecule drug candidates to fill unmet medical needs. It focuses on treating metabolic diseases to minimize their long-term complications through end-organ protection. The company is headquartered in High Point, NC.

Part of Fresenius Medical Care AG, Excorim is a Swedish company that provides medical immunology research. The private company is based in Lund, Sweden. Excorim was acquired by Fresenius Hemocare from Gambro AB on December 14, 1999.

VTVX Holdings I LLC discovers, develops and commercializes human therapeutics to fill unmet medical needs. Its products include a pipeline of small molecule clinical and pre-clinical drug candidates for the treatment of a range of human diseases, including central nervous system disorders, cardiovascular disorders, type I/II diabetes, obesity, metabolic diseases, inflammatory diseases, female sexual dysfunction, primary open angle glaucoma and cancer. The company was founded in 1998 by Dr. Adnan M. M. Mjalli and is headquartered in High Point, NC.